Russellville Hospital Moved Quickly To Bring High-End Technology to Patients HOUSTON, June 5, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, confirmed that Russellville Hospital is the first customer to complete installation and commence scanning on the recently FDA cleared 4cm detector version of the uCT ATLAS. Russellville Hospital is a 49-bed acute care facility serving northwest Alabama. The hospital is fully accredi

A wealth of deep and targeted expertise will aid the company's strategy and support its digital Cytology platform developmentSANTA CLARA, Calif., June 5, 2023 /PRNewswire/ -- AIxMed, an early-stage smart Cytology company at the intersection of artificial intelligence (AI) and medicine, announced the appointment of Cytopathology industry heavyweight Barbara Crothers, D.O., as Chief Scientist. In this new executive leadership role, Dr. Crothers will drive AIxMed's strategic scientific and clinical

Business Activity Index at 51.5%; New Orders Index at 52.9%; Employment Index at 49.2%; Supplier Deliveries Index at 47.7% TEMPE, Ariz., June 5, 2023 /PRNewswire/ -- Economic activity in the services sector expanded in May for the fifth consecutive month as the Services PMI® registered 50.3 percent, say the nation's purchasing and supply executives in the latest Services ISM® Report On Business®. The sector has grown in 35 of the last 36 months, with the lone contraction in December of last y

NEW YORK, June 5, 2023 /PRNewswire/ -- Hospital for Special Surgery (HSS), the world's leading academic medical center focused on musculoskeletal health, will honor Frank P. Cammisa, Jr., MD, chief emeritus of HSS Spine, and Joe and Clara Wu Tsai, business leaders, philanthropists, and owners of the Brooklyn Nets and the New York Liberty, at its 38th Tribute Dinner on Monday, June 5. The event will be held at the American Museum of Natural History in New York City. Dr. Cammisa will be honored wi

SHANGHAI and NANJING, China and SAN JOSE , Calif., June 5, 2023 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, and Innovent Biologics, Inc. ("Innovent," HKEX: 01801), today jointly announced the updated data from phase 1b/2 study of Equecabtagene Autoleucel (IASO Bio R&D code: CT103A, Innovent R&D code: IBI326), a fully-human anti-B cell maturation a

He will replace Kathleen Skarvan, who is retiring after 10 years at the company. Cunniff joins the company with more than 30 years of executive leadership experience in the medtech industry with demonstrated success in general management, sales and marketing, finance, manufacturing, distribution, mergers and acquisitions. He most recently was president and CEO of Provista, a Vizient company. “We are pleased to announce the appointment of Jim Cunniff as president and CEO,” Board Chair Lee Jones s

LEXINGTON, Mass.--( BUSINESS WIRE )--Agenus (Nasdaq: AGEN), a leading immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, presented complete results from the monotherapy arm of the first-in-human dose escalation study of AGEN2373 (CD137 agonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting. AGEN2373 demonstrated objective responses, clinical benefit, and was well tolerated in heavily pre-treated patients with solid tumors

ST. LOUIS, June 05, 2023 (GLOBE NEWSWIRE) -- Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced positive results from the Company’s pivotal phase III clinical trial of intranasally administered DPI-386 Nasal Gel (scopolamine HBr), which is in late-stage development for the prevention of nausea and vomiting induced by motion. DPI-386 Nasal Gel achieved the primary endpoint in this recently completed, confirma

GE HealthCare (Nasdaq:GEHC) announced today that it launched its now FDA-cleared Sonic DL MRI technology. Chicago-based GE HealthCare developed Sonic DL as a state-of-the-art deep learning-based technology. The company designed it to accelerate image acquisition in magnetic resonance imaging (MRI). This platform could enable new imaging paradigms, including high-quality cardiac MRI in a single heartbeat, the company says. It marks the latest addition to the growth AI-enabled product portfolio at

The Brand's Nokamen Is a Uroprotector Designed to Support the Natural Resolution of Urolithiasis FORT LAUDERDALE, Fla., June 5, 2023 /PRNewswire/ -- Urolithiasis (the scientific term for kidney stones) takes place when stony concretions form in the bladder or urinary tract. While the prevalence of urolithiasis varies from region to region, it is common in North America. 13% of American men and 7% of women suffer from the condition. There are not many easy solutions to resolve kidney stones. Comm